Clinical Trial Update: Psilocybin for Hospitalized Patients with Treatment-resistant Depression [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial tests psilocybin in hospitalized patients with treatment-resistant depression. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Treatment-resistant Depression

Drugs mentioned

• Psilocybin (psilocybin)

Snippet

Sponsor: University Hospital, Ghent | Conditions: Treatment Resistant Depression | Phase 2 | Status: RECRUITING